Every recall we track for Edge Pharma, LLC — 62 in all — plus the complaints and injury reports the public filed about them.
Edge Pharma recalls sterile phenylephrine injection due to lack of assurance of sterility. Affected units sold from 2021-2022; consumers should contact Edge Pharma for details.
Edge Pharma recalls 4% Tetracaine HCl Nasal Solution due to CGMP deviations. This may affect safety and quality of the product. Consumers should check their bottles for NDC 05446-1195-03.
Edge Pharma recalls methotrexate injections due to potential contamination risks. This affects specific lot numbers from 2021-2022. Consumers should contact the manufacturer for details.
Edge Pharma recalls 50mg/30mg/5mg sulfacetamide ciprofloxacin amphotericin B otic powder due to manufacturing deviations. No specific remedy stated in recall notice.
Edge Pharma recalls sterile ophthalmic solution for injection due to lack of sterility assurance. This may cause infections if used improperly. Contact for details.
Edge Pharma recalls 1,250 mg/250 mL Vancomycin HCl IV injection due to lack of sterility assurance. Affected units were sold from December 2021 to January 2022. Consumers should contact Edge Pharma for details.
Edge Pharma recalls 4%/1% nasal solution due to CGMP deviations. Affected products have NDC 05446-1045-03. Consumers should contact Edge Pharma for details.
Edge Pharma recalls lidocaine/tetracaine topical cream due to manufacturing deviations. Affected units have specific NDC numbers and were sold between 2021-2022. Consumers should check product details and contact Edge Pharma for guidance.
Edge Pharma recalls Trypan Blue 0.03% ophthalmic solution due to CGMP deviations. This sterile injection solution for eye use may have manufacturing issues. Consumers should contact the company for details.
Edge Pharma recalls PHENYLephrine 0.9% Sodium Chloride Injection (20 mg/250mL) due to lack of sterility assurance. This product may cause infections if used improperly.
Edge Pharma recalls lidocaine/bupivacaine ophthalmic solution due to lack of sterility assurance. This could cause infections if used improperly. Affected products include specific syringe sizes and batch numbers from 2021.
Edge Pharma recalls sterile vancomycin ophthalmic solution due to lack of sterility assurance. This may cause infections if used improperly.
Edge Pharma recalls Methacholine Challenge 5-Syringe Test Kits due to lack of sterility assurance. This could lead to infections if used improperly. Consumers should contact the manufacturer for details.
Edge Pharma recalls 0.7% Cantharidin Gel-Forming Suspension (10mL vials) due to CGMP deviations. This may affect product safety. Check NDC 05446-0572-03 for affected items.
Edge Pharma recalls 5mL single-use IV syringes for phenylephrine HCl 0.5mg/5mL due to lack of sterility assurance. This could lead to infections if used improperly.
Edge Pharma recalls 0.5mL eye drops due to potential contamination. This could cause infection if used. Check NDC 05446-0993-01 for affected products.
Edge Pharma recalls Mitomycin-C syringes due to lack of sterility assurance. This could lead to infections if used improperly. Consumers should contact the manufacturer for details.
Edge Pharma recalls 6% Phenol Sterile Solution for Injection vials due to lack of assurance of sterility. This could lead to infections if used improperly. Check your vials for NDC 05446-1476-05.
Edge Pharma recalls sterile eye drops with potential contamination risk. Consumers should check NDC 05446-0815-01 for affected products.
Edge Pharma recalls sterile ophthalmic solution for potential contamination risks. This product may not be sterile, causing eye infections. Consumers should contact Edge Pharma for details.
Edge Pharma recalls CSF-HC Otic Insufflation Capsule powder for potential manufacturing deviations. Affected products include 50mg/30mg/25mg/5mg bottles with specific NDC numbers and dates.
Edge Pharma recalls sterile ophthalmic solution for injection due to lack of sterility assurance. This may cause infections if used improperly. Contact for return instructions.
Edge Pharma recalls neostigmine methylsulfate syringes due to lack of sterility assurance. This could lead to infections if used improperly. Affected products were sold from 2021 to 2022.
Edge Pharma recalls 1% Lidocaine HCl Sterile Buffered Solution for injection due to lack of sterility assurance. This may cause infections if used improperly.
Edge Pharma recalls 10%/1%/0.3%/0.125% ophthalmic solution due to lack of sterility assurance. This may cause infections. Check NDC 05446-1270-01 for affected units.
Edge Pharma recalls 0.4% Dexamethasone sodium phosphate topical cream due to CGMP deviations. Affected units may have quality issues affecting safety.
Edge Pharma recalls Profound Dental Gel (NDC 05446-0407-10) due to CGMP deviations. Consumers should check product dates and contact Edge Pharma for details.
Edge Pharma recalls sterile ophthalmic solution for injection due to lack of sterility assurance. This may cause infections if used improperly. Contact for details.
Edge Pharma recalls 1,500 mg/500 mL Vancomycin HCl injection due to lack of sterility assurance. Affected products were sold in the US starting August 2021. Consumers should contact the manufacturer for details.
Edge Pharma recalls 30g Raspberry Marshmallow dental gel with CGMP deviations. Products sold from July 2021 to April 2022 may pose quality risks. Consumers should contact Edge Pharma for details.
Edge Pharma recalls IV bags of ALUM Concentrate (Aluminum Potassium Sulfate Dodecahydrate) due to lack of sterility assurance. This may cause infections if used improperly.
Edge Pharma recalls 1,750mg/500mL Vancomycin HCl IV injection due to lack of sterility assurance. Affected units were sold from December 2021 to January 2022. Consumers should contact Edge Pharma for details.
Edge Pharma recalls Profound-PE Dental Gel due to CGMP deviations. This dental gel may not meet safety standards. Consumers should check product details and contact Edge Pharma for updates.
Edge Pharma recalls 10mL ophthalmic solution with potential lack of sterility. This could cause infection if used. Affected units sold Dec 2021.
Edge Pharma recalls Vancomycin HCl Oral Solution (PF) 125mg/2.5mL due to CGMP deviations. Affected units have specific NDC and batch numbers. Consumers should contact Edge Pharma for details.
Edge Pharma recalls 4% Lidocaine / 0.05% Oxymetazoline nasal solution due to CGMP deviations. No specific remedy stated in recall notice.
Edge Pharma recalls sterile eye injection solution due to potential contamination risks. Affected units sold between Dec 2021 and Jan 2022. Consumers should contact the company for details.
Edge Pharma recalls 1% Dibutyl Squaric Acid topical solution vials produced between August 2021 and February 2022 due to manufacturing quality issues. Consumers should check product details and contact the company for updates.
Edge Pharma recalls Mitomycin-C Sterile Ophthalmic Solution due to lack of sterility assurance. This product may cause infections if used improperly. Consumers should contact the manufacturer for details.
Edge Pharma recalls sterile ophthalmic solution for injection due to lack of assurance of sterility. This may cause infections if used improperly.
Edge Pharma recalls BLT Topical Cream (20%/8%/4% Benzocaine/Lidocaine/Tetracaine) due to CGMP deviations. Consumers should check NDC 05446-1235-01 for affected products.
Edge Pharma recalls sterile lidocaine/epinephrine injection due to lack of assurance of sterility. This could cause infections if used improperly.
Edge Pharma recalls multiple batches of Cantharidin PLUS and Cantharidin/Salicylic Acid Gel-Forming Suspension for potential quality issues. Consumers should check product labels for NDC 05446-0970-03 and affected dates.
Edge Pharma recalls Betadine sterile ophthalmic solution due to lack of assurance of sterility. This could lead to infections if used improperly. Affected products were sold from 2021.
Edge Pharma recalls Vitamin K Oral Solution (5 mg/mL) due to CGMP deviations. This may affect safety but no specific harm is confirmed. Check your product's NDC 05446-1132-03 for details.
Edge Pharma recalls 2.5% Promethazine HCl topical ointment due to CGMP deviations. Affected units have specific NDC and batch numbers. Consumers should contact Edge for details.
Edge Pharma recalls LET Topical Gel (4%/0.05%/0.5%) due to CGMP deviations. Affected units sold from 2021-07 to 2022-03. No remedy specified in recall notice.
Edge Pharma recalls single-use IV syringes due to lack of sterility assurance. Affected products were sold between December 2021 and February 2022. Consumers should contact the company for details.
Edge Pharma recalls sterile dexamethasone otic solution due to lack of assurance of sterility. This may cause infections if used improperly. Affected products were sold from 2021-2022.
Edge Pharma recalls 2% Dibutyl Squaric Acid topical solution vials due to CGMP deviations. Affected products were sold between October and December 2021. Consumers should contact the company for details.
Edge Pharma recalls gemcitabine solution due to lack of assurance of sterility. This may cause infections. Check product details and contact for remedy.
Edge Pharma recalls Profound-PE Dental Gel (10% Lidocaine/10% Prilocaine/4% Tetracaine/2% Phenylephrine) due to CGMP deviations. Affected units sold between August 2021 and December 2021. No remedy specified in recall notice.
Edge Pharma recalls phenol topical solution vials due to CGMP deviations. These vials may not meet safety standards. Consumers should check product details and contact Edge Pharma for guidance.
Edge Pharma recalls MVASI (bevacizumab-awwb) ophthalmic solution for injection due to lack of sterility assurance. This affects specific lot numbers sold from December 2021. Consumers should contact the manufacturer for details.
Edge Pharma recalls sterile ophthalmic solution (3% EDTA) due to lack of sterility assurance. Affected products were sold from January 2022. Consumers should contact the company for details.
Edge Pharma recalls sterile ophthalmic solution with potential contamination risk. Affected units may cause eye infections if used. Consumers should contact Edge Pharma for details.
